
CALIGAN PARTNERS LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | LQDA | 8.12M | $280.02M |
![]() | TNGX | 3.73M | $33.05M |
![]() | ADMA | 3.01M | $54.95M |
![]() | MLYS | 2.77M | $100.62M |
![]() | IVA | 2.00M | $9.30M |
![]() | PCVX | 1.70M | $78.66M |
![]() | EXEL | 1.55M | $68.08M |
![]() | ABVX | 1.45M | $195.80M |
![]() | ANIK | 1.44M | $13.79M |
![]() | RVMD | 1.28M | $102.26M |
![]() | TYRA | 944K | $24.82M |
![]() | VOR | 925K | $9.96M |
![]() | VRCA | 924K | $7.68M |
![]() | AVTX | 882K | $16.01M |
![]() | RAPT | 644K | $21.83M |
![]() | ELDN | 556K | $839.53K |
![]() | MAZE | 550K | $22.79M |
![]() | XENE | 550K | $24.64M |
![]() | INBX | 324K | $25.56M |
![]() | SPRB | 21K | $1.79M |

Liquidia Corporation
LQDA
Shares Held
8.12M
Value
$280.02M

Tango Therapeutics, Inc.
TNGX
Shares Held
3.73M
Value
$33.05M

ADMA Biologics, Inc.
ADMA
Shares Held
3.01M
Value
$54.95M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
2.77M
Value
$100.62M

Inventiva S.A.
IVA
Shares Held
2.00M
Value
$9.30M

Vaxcyte, Inc.
PCVX
Shares Held
1.70M
Value
$78.66M

Exelixis, Inc.
EXEL
Shares Held
1.55M
Value
$68.08M

Abivax S.A.
ABVX
Shares Held
1.45M
Value
$195.80M

Anika Therapeutics, Inc.
ANIK
Shares Held
1.44M
Value
$13.79M

Revolution Medicines, Inc.
RVMD
Shares Held
1.28M
Value
$102.26M

Tyra Biosciences, Inc.
TYRA
Shares Held
944K
Value
$24.82M

Vor Biopharma Inc.
VOR
Shares Held
925K
Value
$9.96M

Verrica Pharmaceuticals Inc.
VRCA
Shares Held
924K
Value
$7.68M

Avalo Therapeutics, Inc.
AVTX
Shares Held
882K
Value
$16.01M

RAPT Therapeutics, Inc.
RAPT
Shares Held
644K
Value
$21.83M

Eledon Pharmaceuticals, Inc.
ELDN
Shares Held
556K
Value
$839.53K

Maze Therapeutics, Inc.
MAZE
Shares Held
550K
Value
$22.79M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
550K
Value
$24.64M

Inhibrx Biosciences, Inc.
INBX
Shares Held
324K
Value
$25.56M

Spruce Biosciences, Inc.
SPRB
Shares Held
21K
Value
$1.79M
